CD8A and neoplasm: Additionally, CAFs inhibit the function of CD8+ T cells, promote Treg recruitment, and suppress their tumor cell killing abilities by reducing T cell infiltration into the tumor, thus impeding T cell trafficking within the TME and inhibiting cytotoxic activity [37].